Sanofi Augments its Biosurgery Unit with Pluromed Acquisition
By Heather Cartwright
Pharma Deals Review: Vol 2012 Issue 3 (Table of Contents)
Published: 26 Mar-2012
DOI: 10.3833/pdr.v2012.i3.1705 ISSN: 1756-7874
Section: Mergers & Acquisitions
Fulltext:
Abstract
Sanofi has agreed to buy the US medical device company Pluromed in order to strengthen the biosurgery portfolio it gained via its takeover of Genzyme in 2011...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS